THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Laurion Capital Management LP's Holding History (CIK: 0001390202)

Note: Option positions (PUT/CALL) are excluded.

Q3 2021
Shares 27,095 Value ($000) $201 Avg Close $11.19 Range $6.10 - $15.01
Q2 2021
Shares 1,094,936 Value ($000) $15,898 Avg Close $18.78 Range $14.46 - $22.74
Q1 2021
Shares 704,608 Value ($000) $14,381 Avg Close $19.01 Range $16.46 - $21.21
Q4 2020
Shares 641,235 Value ($000) $11,395 Avg Close $17.95 Range $14.48 - $20.53
Q3 2020
Shares 19,481 Value ($000) $288 Avg Close $18.73 Range $14.62 - $22.82
Q2 2020
Shares 244,471 Value ($000) $5,131 Avg Close $25.69 Range $20.17 - $31.35
Q1 2020
Shares 300,000 Value ($000) $6,933 Avg Close $25.03 Range $16.86 - $31.54
Q4 2019
Shares 77,528 Value ($000) $2,007 Avg Close $19.43 Range $15.72 - $26.47
Q2 2018
Shares 61,110 Value ($000) $1,386 Avg Close $23.74 Range $21.27 - $26.00
Q1 2018
Shares 281,055 Value ($000) $6,816 Avg Close $27.46 Range $22.90 - $30.29
Q3 2014
Shares 74,370 Value ($000) $1,714 Avg Close $29.01 Range $23.01 - $34.07
Q2 2014
Shares 124,872 Value ($000) $3,981 Avg Close $27.05 Range $14.75 - $35.67